Precigen (PGEN) revenue and earnings history
Precigen reported revenue of $9.68M for fiscal 2025 (year ended Dec 31, 2025), +146.7% on the year before, and net income of −$251M.
Over 14 years, from fiscal 2011 to fiscal 2025, revenue grew at a compound rate of +1.4% a year.
Revenue and net income, 15 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $9.68M+146.7% | −$111M | −$251M | −$87.8M | $2M | −$89.8M | $10.9M | — | — | $30.2M | $93.2M | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Precigen (PGEN) on OQRO.
Common questions
What was Precigen's revenue in fiscal 2025?
$9.68M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 25, 2026. That is +146.7% on fiscal 2024 ($3.92M).
How fast has Precigen's revenue grown?
From $8.01M in fiscal 2011 to $9.68M in fiscal 2025: a compound annual growth rate of +1.4% over 14 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Precigen been profitable?
Where these figures come from
The SEC’s companyfacts data: every figure Precigen tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
